Back then, Celera Genomics (nyse: CRA - news - people ) and the publicly funded Human Genome Project (HGP) had yet to show off their drafts of the human DNA sequence and Celera's market cap was nearly eight times what it is now.
FORBES: DeCode's Genetic Breakthrough Barely Registers